|
VRTX | Vertex Pharmaceuticals Inc / Ma |
|
|
VRTX | Vertex Pharmaceuticals Inc / Ma |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.16 |
| Leverage | 27.21% |
| Market Cap | $ 116.6B |
| PE | 29.60 |
| Dividend Yield | 0.00% |
| Profit | $ 3.9B |
| Margin | 32.93% |
Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.